Mettler-Toledo International Inc. (NYSE:MTD) Insider Christian Magloth Sells 790 Shares

Mettler-Toledo International Inc. (NYSE:MTD) insider Christian Magloth sold 790 shares of the firm’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Mettler-Toledo International Price Performance

NYSE MTD traded down $21.51 on Wednesday, hitting $1,287.38. 39,416 shares of the company were exchanged, compared to its average volume of 134,986. The firm has a market capitalization of $26.93 billion, a P/E ratio of 31.75, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. The company’s 50 day moving average price is $1,287.86 and its 200-day moving average price is $1,331.78. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its stake in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Quest Partners LLC raised its stake in Mettler-Toledo International by 878.1% during the 3rd quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock valued at $1,540,000 after buying an additional 922 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares during the period. M&T Bank Corp lifted its holdings in shares of Mettler-Toledo International by 14.3% in the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after buying an additional 615 shares in the last quarter. Finally, Allworth Financial LP lifted its stake in Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after purchasing an additional 169 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the company from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Finally, Evercore ISI raised their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $1,368.00.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.